Short answer
Charles River Laboratories (CRL) filed an 8-K current report with the SEC on May 11, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 5.07 (Submission of Matters to a Vote of Security Holders). Shareholders approved CRL’s 2026 Long-Term Incentive Plan at the May 5, 2026 annual meeting.
Charles River Laboratories 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Shareholders approved CRL’s 2026 Long-Term Incentive Plan at the May 5, 2026 annual meeting
- Plan enables future equity-based compensation for executives and other eligible employees
- Board approval occurred March 11, 2026, contingent on shareholder approval
- Key terms appear in the March 31, 2026 Proxy Statement and Exhibit 10.1
Item 5.07 · Submission of Matters to a Vote of Security Holders
- All 12 director nominees re-elected through 2027, with Abraham Ceesay receiving the weakest support: 35,798,426 votes for
- Executive compensation approved 41,356,139 to 2,716,251, supporting management’s pay framework
- 2026 Long-Term Incentive Plan approved 41,523,179 to 2,561,994, authorizing continued equity-based compensation
- PwC auditor appointment ratified 43,646,371 to 2,186,700, preserving the existing audit relationship
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Charles River Laboratories 8-K filings
Get the next CRL 8-K as it lands
Follow CRL for push alerts, or ask the research agent what this filing means.